Performance Assessment of the Fluorescence Technique Alone in the Search for the Sentinel Node in Breast Surgery
NCT05588414 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 392
Last updated 2025-02-13
Summary
Cohort, interventional, multicenter, non-randomized study to compare the performance of the ICG fluorescence technique (ICG) alone to the combined ICG + isotopic technique in the detection of sentinel node.
Comparison of the performances of two techniques used in current practice, without modification of the patients' care plan. Indeed, all patients receive both techniques, but the protocol allows to standardize the collection of the performances of each of the two techniques in order to compare them.
Conditions
Interventions
- PROCEDURE
-
Standardization of the sentinel node detection procedure
All patients included in the study underwent the same pre- and intra-operative procedure, consisting of a double systematic sentinel node detection, using sequential ICG and isotopic technique. The patient is his own control for the analysis of the performance of the ICG technique alone compared to the combined ICG and isotopic technique.
Sponsors & Collaborators
-
Centre Hospitalier Annecy Genevois
lead OTHER
Principal Investigators
-
Didier TARDIF, Doctor · Centre Hospitalier Annecy Genevois
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-05
- Primary Completion
- 2024-06-27
- Completion
- 2024-06-27
Countries
- France
Study Locations
More Related Trials
-
Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy
NCT06212440 ·Status: COMPLETED ·Phase: NA
-
Sentinel Lymph Node Identification in Patients With Breast Cancer Using SPECT/CT
NCT03468374 ·Status: UNKNOWN ·Phase: NA
-
Trop2-targeting NIR-II Molecular Probe for Breast Cancer Precise Surgery
NCT06713681 ·Status: COMPLETED
-
Cost of Using FLUOrescence to Green of Indocyanine for the Detection of Breast Cancer.
NCT05699291 ·Status: COMPLETED
-
Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer
NCT02168452 ·Status: COMPLETED
-
Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer
NCT02481128 ·Status: COMPLETED ·Phase: NA
-
Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer
NCT02279108 ·Status: COMPLETED ·Phase: PHASE3
-
Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients
NCT06780748 ·Status: RECRUITING ·Phase: PHASE2
-
Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer
NCT00909441 ·Status: COMPLETED ·Phase: NA
-
Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer Patients
NCT02479997 ·Status: COMPLETED ·Phase: PHASE2
-
Sentinel Lymph Node Biopsy in Breast Cancer Surgery Using ICG
NCT03579979 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating Near-infrared Zone II Imaging in Sentinel Lymph Node Mapping in Breast Cancer Patients
NCT05365191 ·Status: UNKNOWN ·Phase: NA
-
Role of Indocyanine Green (ICG) for Detection of Sentinel Nodes in Breast Cancer
NCT02875626 ·Status: COMPLETED ·Phase: NA
-
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Initially Node Positive Breast Cancer Patients, Could it Omit Axillary Dissection ?
NCT06130241 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Sentinel Lymph Node Detection After Neoadjuvant Chemotherapy for Large Operable Breast Cancer
NCT01221688 ·Status: COMPLETED ·Phase: NA
-
Identification of New Prognostic Markers for Breast Cancer.
NCT03436069 ·Status: RECRUITING
-
Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy for Ductal Carcinoma in Situ: Identifying Eligible Candidates
NCT05961280 ·Status: COMPLETED
-
Sentinel Lymph Node Biopsy in Patients With Breast Cancer After Neoadjuvant Therapy
NCT03556397 ·Status: COMPLETED ·Phase: NA
-
Omitting Biopsy of SEntinel Lymph Node With Radiation After Neoadjuvant Chemotherapy in Breast Cancer (OBSERB) Trial
NCT04116125 ·Status: UNKNOWN ·Phase: NA
-
Indocyanine Green Fluorescence-guided Sentinel Node Biopsy in Breast Cancer Within a North African Population: a Retrospective Study
NCT04879680 ·Status: COMPLETED
-
Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients
NCT05703295 ·Status: UNKNOWN
-
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients
NCT00893035 ·Status: COMPLETED
-
Clinical Application of Near-infrared Fluorescence Guided Localization on Breast Surgery in Breast Cancer
NCT02473159 ·Status: UNKNOWN ·Phase: PHASE2
-
Preoperative Localisation of the Sentinel Lymph Node in Breast Cancer
NCT01154972 ·Status: COMPLETED ·Phase: NA
-
Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status
NCT06713161 ·Status: RECRUITING